The Impact of Pregnancy on Diabetic Retinopathy: A Single-Site Study of Clinical Risk Factors.

Ophthalmic Res · 2023 · PMC10614555 · PMID 37573783

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

not significantly significantno p-value reported

The “progression” group had higher rates of intravitreal injections to treat DR during pregnancy with 14.8% (4/27) receiving either Eylea or Avastin while 1 patient in the “non-progression” received injections, though this was not significantly significant.

also in 164 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.